Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

This study has been completed.
University Medical Center Freiburg - Clinical Trials Unit
Information provided by (Responsible Party):
Neovii Biotech Identifier:
First received: April 3, 2008
Last updated: December 9, 2011
Last verified: December 2011